- Conversion Labs (OTCQB:CVLB) announced an equity investment by a select group of private investors and family offices, including investors David Blitzer and Wes Edens, for $3.5M.
- The company also submitted its application to list its common stock on Nasdaq.
- The company's annualized revenue run-rate recently exceeded $44M compared to $12.5M for all of 2019, driven by the increasingly popular proprietary brands and formulas that include Rex MD and Shapiro MD.